Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients

Overview

Journal Am J Ther

Specialty Pharmacology

Date 2021 Jul 15

PMID 34264890

Authors

Scott J Morin

Chinmay Jani

Arashdeep Rupal

Harpreet Singh

Daniel Bourque

Robert C Colgrove

Affiliations

Soon will be listed here.

References

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

Rosa Junior M, Borges E, Fonseca A, Fiorot J, Balarini L, Valim V . Posterior reversible encephalopathy syndrome during treatment with tocilizumab in juvenile idiopathic arthritis. Arq Neuropsiquiatr. 2018; 76(10):720-721. DOI: 10.1590/0004-282X20180093. View

Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M . Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020; 2(8):e474-e484. PMC: 7314456. DOI: 10.1016/S2665-9913(20)30173-9. View

Kushner B, Modak S, Basu E, Roberts S, Kramer K, Cheung N . Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody. Cancer. 2013; 119(15):2789-95. PMC: 4326066. DOI: 10.1002/cncr.28137. View

Stone J, Frigault M, Serling-Boyd N, Fernandes A, Harvey L, Foulkes A . Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020; 383(24):2333-2344. PMC: 7646626. DOI: 10.1056/NEJMoa2028836. View

Xu X, Han M, Li T, Sun W, Wang D, Fu B . Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020; 117(20):10970-10975. PMC: 7245089. DOI: 10.1073/pnas.2005615117. View

Talluri K, Lall N, Moreno M, Nichols L, Bande D . Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab. Cureus. 2021; 13(2):e13475. PMC: 7987818. DOI: 10.7759/cureus.13475. View

Hermine O, Mariette X, Tharaux P, Resche-Rigon M, Porcher R, Ravaud P . Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2020; 181(1):32-40. PMC: 7577198. DOI: 10.1001/jamainternmed.2020.6820. View

Evans S, Repasky E, Fisher D . Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015; 15(6):335-49. PMC: 4786079. DOI: 10.1038/nri3843. View

10.

Gritti G, Raimondi F, Bottazzi B, Ripamonti D, Riva I, Landi F . Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021; 35(9):2710-2714. PMC: 8142063. DOI: 10.1038/s41375-021-01299-x. View

11.

Salvarani C, Dolci G, Massari M, Merlo D, Cavuto S, Savoldi L . Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2020; 181(1):24-31. PMC: 7577199. DOI: 10.1001/jamainternmed.2020.6615. View

12.

Shimabukuro-Vornhagen A, Godel P, Subklewe M, Stemmler H, Schlosser H, Schlaak M . Cytokine release syndrome. J Immunother Cancer. 2018; 6(1):56. PMC: 6003181. DOI: 10.1186/s40425-018-0343-9. View

13.

Alzghari S, Acuna V . Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review. J Clin Virol. 2020; 127:104380. PMC: 7194791. DOI: 10.1016/j.jcv.2020.104380. View